What do you mean commercial version. You mean approved commercially by the notified body like the MIA human approval we received earlier this month. If so, this ain't happening for another 18-24 months at a minimum.
Either way, the answer is no. I would rather start the trial with a manual version given the uncertainty around the validation and approval of Flaskworks. Timing and certainty is of essence to big pharma. Flaskworks will not be used by big pharma in a clinical trial unless it has gone through the necessary approvals. Not much value in seeing some unapproved devices installed for testing and validation but no formal approvals.
What you’re suggesting is that a big pharma has already agreed in principle to a combo trial deal but wont initiate it until Flaskworks is ready to be deployed. That sounds so silly when the manual method is already approved commercially while there is great deal of uncertainty around Flaskworks validation. Forget about approvals.
The other thing you have proven is that you have no confidence in Flaksworks being approved (even for clinical trial use) for another 9 months or so. Not much different than the 1 year timeline I gave for non commercial approval and that too if we are lucky and everything goes according to plan.
Market Data 
Markets 
